Delayed toxicity of cyclophosphamide in normal mice

Area of Science:

• Immunology
• Toxicology
• Cell Biology

Background:

• Cyclophosphamide (CP) is a widely used chemotherapeutic agent.
• Delayed toxicity of CP can manifest as wasting disease and increased mortality.
• The thymus plays a crucial role in T-cell development and immune function.

Purpose of the Study:

• To investigate the delayed toxicity of a single dose of cyclophosphamide (CP) in female DBA/2 mice.
• To elucidate the mechanisms underlying CP-induced wasting disease and thymic involution.
• To explore potential therapeutic interventions for CP-induced delayed mortality.

Main Methods:

• Administration of a single dose of 300 mg/kg cyclophosphamide (CP) to female DBA/2 mice.
• Monitoring of survival rates, body weight, and hematological parameters.
• Histological and electron microscopy analysis of thymus tissue.
• Histochemical staining for lysosomal enzyme activity.
• Assessment of the effects of bone marrow cell injection and thymus transplantation on delayed lethality.

Main Results:

• Cyclophosphamide induced a marked increase in mortality peaking between 50-70 days post-treatment, with over 80% mortality by day 120.
• Mice exhibited wasting disease, characterized by weight loss and significant lymphocyte depletion.
• Histochemical analysis revealed increased lysosomal enzyme activity and signs of thymic involution, including cystic formations and degradation.
• Delayed mortality was partially prevented by syngenic bone marrow cell injection but not by thymus transplants.
• These findings suggest CP-induced delayed toxicity is secondary to primary injury to pre-T cells in the bone marrow.

Conclusions:

• Cyclophosphamide induces a delayed wasting syndrome and thymic involution in mice.
• The observed thymic pathology is likely a secondary effect, not a direct impact on thymus structures.
• CP primarily injures pre-T cells in the bone marrow, leading to subsequent immune dysregulation and delayed mortality.
• Bone marrow cell transplantation shows potential in mitigating CP-induced delayed toxicity.